Home/Quretech Bio/Annica Rönnbäck
AR

Annica Rönnbäck

COO

Quretech Bio

Quretech Bio Pipeline

DrugIndicationPhase
GmPcide ProgramBacterial Infections (Gram-positive, e.g., MRSA, E. faecalis)Pre-clinical